<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Generic Drugs on Lynx Tech Blog</title><link>https://blog.lynxflow.co/en/tags/generic-drugs/</link><description>Recent content in Generic Drugs on Lynx Tech Blog</description><generator>Hugo -- gohugo.io</generator><language>en</language><lastBuildDate>Fri, 04 Sep 2026 19:30:00 +0800</lastBuildDate><atom:link href="https://blog.lynxflow.co/en/tags/generic-drugs/index.xml" rel="self" type="application/rss+xml"/><item><title>Expired Patent Intelligence: Mining Entrepreneurial Opportunities from Global Expired Patents</title><link>https://blog.lynxflow.co/en/posts/expired-patent-intelligence-startup-opportunities/</link><pubDate>Fri, 04 Sep 2026 19:30:00 +0800</pubDate><guid>https://blog.lynxflow.co/en/posts/expired-patent-intelligence-startup-opportunities/</guid><description>&lt;img src="https://blog.lynxflow.co/images/expired-patent-intelligence-cover.png" alt="Featured image of post Expired Patent Intelligence: Mining Entrepreneurial Opportunities from Global Expired Patents" /&gt;Every year, patents protecting billions of dollars in revenue expire—and behind these expired patents lies a massive opportunity landscape. From generic drugs to drug repurposing, from technical standards to manufacturing processes, each &amp;ldquo;patent cliff&amp;rdquo; that drops suddenly opens up previously monopolized technological space to everyone. The global generic drug market was valued at $410–490 billion in 2024, and by 2030 approximately 200 drugs will face patent expiration, representing $</description></item></channel></rss>